Wells Fargo & Company Neuro Metrix, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.61 - $0.98 $4 - $6	7 Added 12.5%	63 $0
Q2 2023 Aug 15, 2023	BUY	$0.92 - $1.48 $1 - $2	2 Added 3.7%	56 $0
Q1 2023 May 12, 2023	BUY	$1.43 - $2.0 $1 - $2	1 Added 1.89%	54 $0
Q4 2022 Feb 13, 2023	BUY	$1.36 - $22.72 $8 - $136	6 Added 12.77%	53 $0
Q3 2022 Nov 14, 2022	SELL	$2.97 - $23.6 $2 - $23	-1 Reduced 2.08%	47 $0
Q2 2022 Aug 12, 2022	BUY	$2.81 - $5.5 $14 - $27	5 Added 11.63%	48 $0
Q1 2022 May 16, 2022	BUY	$3.42 - $6.37 $6 - $12	2 Added 4.88%	43 $0
Q4 2021 Feb 14, 2022	BUY	$5.02 - $9.82 $30 - $58	6 Added 17.14%	41 $0
Q3 2021 Nov 15, 2021	BUY	$3.23 - $24.73 $35 - $272	11 Added 45.83%	35 $0
Q2 2021 Aug 16, 2021	SELL	$2.72 - $3.8 $2 - $3	-1 Reduced 4.0%	24 $0
Q1 2021 May 13, 2021	BUY	$3.01 - $5.35 $6 - $10	2 Added 8.7%	25 $0
Q3 2020 Nov 05, 2020	BUY	$1.48 - $2.26 $20 - $31	14 Added 155.56%	23 $0
Q1 2020 May 14, 2020	BUY	$0.86 - $4.75 $7 - $42	9 New	9 $0

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $30.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.